Optimising malignant melanoma management in Europe
EUMelaReg collects health information to improve care and treatment for patients with skin cancer
Sustaining and fostering collaboration between academia and industry
for the collection of baseline, treatment and outcome data of representative samples of malignant melanoma patients of major European countries.
Building the largest and quickest melanoma registry in the world
EUMelaReg collects real-world data on melanoma patients throughout Europe and integrates them in a data warehouse.

Successful EMR-SEQ Poster presentation at ASCO 2022

Our first, already mentioned in the last newsletter, EUMelaReg abstract submission of the EMR-SEQ project (registry-based outcome analysis of 1,000 patients with BRAF V600 mutant metastatic melanoma in Europe treated with either immune checkpoint or BRAF/MEK inhibition) for the ASCO was successfully presented there. The poster received a lot of attention, and the feedback was extremely positive. We would like to pass this on to the group of authors and take this success with us as motivation for our further register work.